Abstract
The serum CA125 level was determined by a one-step immunoradiometric assay method in patients with lung cancer. Increased serum CA125 levels were observed in 37.8% of patients with squamous cell cancer, in 30.0% of those with adenocarcinoma and in 60.0% of those with small call cancer. Most patients with increased serum CA125 levels were in stages 3 or 4. Patients with pleural effusions or ascites showed high serum CA125 levels. The survival time was significantly shorter in patients with increased serum CA125 levels than in those within normal limits. Among patients with advanced disease (stages 3 and 4), an increased serum CA125 level was again a poor prognostic factor (P less than 0.01). The existence of a pleural effusion did not correlate with the survival time. We conclude that CA125 is a good indicator of disease extent and serum levels correlate to the length of survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kimura, Y., Fujii, T., Hamamoto, K. et al. Serum CA125 level is a good prognostic indicator in lung cancer. Br J Cancer 62, 676–678 (1990). https://doi.org/10.1038/bjc.1990.355
Issue Date:
DOI: https://doi.org/10.1038/bjc.1990.355
This article is cited by
-
Fluorescent paper strip immunoassay with carbon nanodots@silica for determination of human serum amyloid A1
Microchimica Acta (2021)
-
Prognostic value of cancer antigen -125 for lung adenocarcinoma patients with brain metastasis: A random survival forest prognostic model
Scientific Reports (2018)
-
Serum CA125 level predicts prognosis in patients with multiple brain metastases from non-small cell lung cancer before and after treatment of whole-brain radiotherapy
Medical Oncology (2014)
-
Lung tumour markers in oncology practice: a study of TPA and CA125
British Journal of Cancer (2002)